 |
|
|
| |
LONG-TERM SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE IN
CHRONIC HEPATITIS B PATIENTS - FINAL 8-YEAR RESULTS OF 2 PHASE 3 STUDIES
|
| |
| |
DDW 2024 May 18-21 Wash DC
Prof. Calvin Q. Pan
Author(s): Young-Suk Lim, Henry L. Chan, Kosh Agarwal, Patrick Marcellin, maurizia R. Brunetto, Wan-Long Chuang, Harry L. Janssen, Scott Fung, Namiki Izumi, Maciej Jablkowski, Frida Abramov, Hongyuan Wang, Leland J. Yee, John F. Flaherty, Calvin Q. Pan, . Shalimar, Wai-Kay Seto, Edward Gane, Maria Buti
|
| |
|
|
|
|
|
